Background: Aging is associated with impaired ischemia-induced neovascularization. However, the effects of aging on bone marrow-derived angiogenic cell (BMDAC)-mediated vasculogenesis and on angiogenesis at the ischemic sites remain incompletely understood. Methods and results: Two-and 24-month old male C57Bl/6J mice were subjected to hindlimb ischemia. The levels of Sca1+/CXCR4+ BMDACs were determined post-ischemia by flow cytometry. In young mice, ischemia increased Sca1+/CXCR4+ BMDAC levels in the bone marrow and spleen at day 3 (p b 0.001) and in the circulating blood at day 7 (p b 0.01) post-ischemia. However, ischemia-induced elevation of progenitor cells was attenuated in the bone marrow, spleen and blood of old mice despite a preserved HIF-1α-mediated angiogenic response in the ischemic tissues. Irradiated young recipient mice engrafted with old bone marrow displayed reduced levels of Sca1+/CXCR4+ BMDACs in the bone marrow and circulating blood post-ischemia compared to recipients with young bone marrow. Ex vivo cultured BMDACs from old mice exhibited reduced SDF-1-stimulated migration (p b 0.01) and a decrease in JAK-2 and AKT activation. However, the intrinsic angiogenic function of BMDACs, including VEGF secretion and promotion of endothelial cell tubule formation, was preserved with aging. Furthermore, facilitated mobilization of old bone marrow-derived mononuclear cells to the ischemic hindlimb by intramuscular injection enhanced ischemia-induced neovascularization in old mice in vivo (p b 0.001). Conclusions: The age-related impairment in ischemia-induced neovascularization is largely attributable to a marked attenuation of BMDAC mobilization with a preservation of intrinsic angiogenic function with age.
Introduction
Aging is an unavoidable biological deteriorative process that is associated with a decline in adaptive responses toward different stressors, including ischemia. Aging alone is a major risk factor for coronary and peripheral artery disease and is also associated with increased incidence of other cardiovascular diseases [1] . The majority of cardiovascular disease-related deaths are in elderly individuals aged 75 years and older. Cardiovascular disease in the elderly is hallmarked by impairment in key vascular repair and regeneration processes including ischemiainduced neovascularization [2] [3] [4] [5] [6] [7] . With an increasingly aged global population, there is a need to better understand the mechanisms of age-related impairment in vascular repair in an attempt to provide better therapies for elderly patients with vascular diseases.
Postnatal neovascularization is a key mechanism for cardiovascular repair and regeneration following ischemia that relies on two interrelated processes: vasculogenesis and angiogenesis. Vasculogenesis involves the proliferation and mobilization of angiogenic progenitor cells from the bone marrow into the circulating blood [8] [9] [10] . Bone marrowderived angiogenic progenitor cells (BMDACs) consist of heterogeneous cell populations which have been previously described as endothelial progenitor cells, circulating angiogenic cells or proangiogenic myeloid cells [11] [12] [13] . These progenitor cells with divergent angiogenic capabilities have been shown to promote blood perfusion at the ischemic sites by incorporating into newly formed blood vessels and/or promoting vascular growth by producing angiogenic cytokines [14] [15] . Angiogenesis is defined as the formation of new blood vessels from the preexisting ones. Ischemia-induced upregulation of a transcription factor hypoxiainducible factor-1α (HIF-1α) mediates the expression of angiogenesis-related genes, such as vascular endothelial growth factor (VEGF) and stromal cell-derived factor-1 (SDF-1) [16] [17] [18] . HIF-1α mediated upregulation of SDF-1 facilitates the mobilization of progenitor cells into the circulation through the binding to its receptor, C-X-C receptor 4 (CXCR4) [19] [20] [21] . Upon binding of SDF-1 to its receptor CXCR4, janus kinase (JAK) and phosphatidylinositol 3-kinase (PI3K)/AKT signaling pathways are activated to induce cell mobilization [22] [23] [24] .
To date, the mechanisms underpinning the age-related decline in ischemia-induced neovascularization remain incompletely understood. The relative contribution of changes in the regenerative capacity of circulating progenitor cells ("the seed") versus changes in the proregenerative environment in ischemic tissues ("the soil") to the agerelated impairment in neovascularization remains debated. In this study, we investigated the effect of aging on ischemia-induced neovascularization by using a murine hindlimb ischemia model involving young and aged mice. We also examined the differential effects of aging on the vasculogenic and angiogenic potential of BMDACs in vivo and in vitro.
Methods & materials

Mouse hindlimb ischemia (HLI) model
All animal studies were conducted with ethical approval from the Sydney Local Health District Animal Ethics Committee (#2011-001A). Two-month old male C57Bl/6J mice were purchased from Australian BioResources and 24-month old male C57Bl/6J mice were purchased from the National Institute of Aging (Bethesda, MD). Mice were housed in a temperature-controlled environment with a 12 hour light and 12 hour dark cycle. Under inhalation of methoxyflurane, mice underwent unilateral hindlimb ischemia (HLI) by femoral artery ligation and excision [25] . A sham procedure was performed on the contralateral limb. Adequate anesthesia was confirmed throughout surgery by testing the pedal reflex. Carprofen (5 mg/kg) was used for analgesia, administered subcutaneously following surgery. Mice were monitored daily to determine the need of carprofen administration. Laser Doppler perfusion imaging (LDPI) was performed prior to surgery, post-surgery and at days 3, 5, 7, 10 and 14 post-ischemia (moorLDI2-IR, Moor Instruments, UK). Blood flow was displayed as a heat map, in which dark blue indicated minimal and red indicated maximum blood flow. Blood perfusion ratio was expressed as the ratio of blood flow in the ischemic vs. the non-ischemic limb. Mice were euthanized at the indicated days for experimental purposes.
Mononuclear cell (MNC) isolation
Upon sacrifice, femur and tibia were flushed with phosphatebuffered saline (PBS) to collect bone marrow. Spleens were homogenized in PBS through a 70 μm nylon filter. Mononuclear cells (MNCs) from the bone marrow, blood and spleen were isolated using Lympholytes®-M Cell Separation Media (Cedarlane, Burlington, Ontario). Total counts of mononuclear cells are included in Supplementary Table 1 in the online version at http://dx.doi.org/10.1016/j.ijcme. 2016.05.005. Cells were centrifuged at 740 ×g for 30 min. Buffy coats were collected and washed twice with PBS + 10% fetal bovine serum (FBS) (Sigma-Aldrich, St. Louis, MO). Cells were resuspended in EGM-2 medium (Lonza, Basel, Switzerland) for ex vivo culture and flow cytometry analysis.
Bone marrow transplantation
Young recipient mice were irradiated once at 1000 rad dose prior to bone marrow transplantation. Donor bone marrow cells (BMCs) were flushed from the femur and tibia of young and old mice with RPMI medium (Sigma). Cell suspensions were filtered with a 70 μm nylon mesh and resuspended in the appropriate volume of RPMI for intravenous injection (1 × 10 6 cells in 200 μl RPMI injected per recipient). Following transplantation, recipient mice were kept in a sterile environment for 6 weeks prior to any experimental surgery.
Intramuscular injection of MNCs
Bone marrow MNCs isolated from old donor mice were intramuscularly injected in PBS into old mice immediately after HLI surgery (1 × 10 6 MNCs per recipient). PBS alone was used in control animals.
Blood flow recovery was monitored for 14 days post-ischemia using LDPI.
Immunohistochemistry
Upon sacrifice, thigh adductor muscles were collected and embedded in Tissue-Tek OCT compound (Finetek, New Taipei City, Taiwan). Embedded tissue was snap-frozen in liquid nitrogen and stored at − 80°C until use. Tissue cryosections (7 μm thick) were fixed in cold 3.7% paraformaldehyde for 10 min and rinsed with PBS. Capillary density, arteriolar density and vessel sizes were examined by immunostaining with rat monoclonal anti-laminin (Abcam, Cambridge, UK), rat monoclonal anti-CD31 conjugated to phycoerythrin (Abcam) and mouse monoclonal α-smooth muscle actin conjugated to fluorescein isothiocyanate (FITC) (Sigma). Goat anti-rat IgG conjugated to Alexafluor 350 (Life Technologies, Grand Island, NY) was used as a secondary antibody. The capillary density (positive for CD31+) and arteriolar density (positive for α-smooth muscle actin) and vessel luminal sizes were normalized to the numbers of myocytes.
Immunofluorescence terminal deoxynucleotidyl transferase dUTP nick-end labeling (TUNEL) staining
Apoptotic cells were determined by a DeadEND Fluorometric TUNEL system (Promega), according to the manufacturer's protocol. Briefly, OCT-embedded tissues were fixed with 4% paraformaldehyde for 15 min and washed twice with PBS for 5 min. After incubation in permeabilization solution for 10 min and washing with PBS twice, tissue samples were incubated with TUNEL reaction mixture at 37°C in humid conditions for 1 h and encapsulated by mounting medium Vectashield containing 4′,6-diamidino-2-phenylindole (DAPI) (Vector Laboratories, Burlingame, CA). TUNEL-positive and DAPI-positive cells were counted in ten randomly selected microscopic fields. The percentages of apoptotic cells were expressed as TUNEL-positive cells per total number of DAPI-positive cells.
Flow cytometry analysis
A subset of progenitor cells from bone marrow-derived angiogenic cell (BMDAC) populations was identified as Sca1+/CXCR4+ BMDACs by flow cytometry using the hematopoietic stem cell marker Sca1 and the SDF-1 receptor CXCR4, as previously described [26, 27] . Isolated bone marrow, spleen and blood MNCs were incubated with FcR blocking solution (Miltenyi Biotec, Bergisch Gladbach, Cologne) according to the manufacturer's protocol at 4°C for 15 min. Cells were then labelled with anti-mouse Sca1-V450 and anti-mouse CXCR4-APC (BD Bioscience, San Jose, CA) at 4°C for 30 min. Cells were then washed twice with PBS + 10% FBS and resuspended in PBS + 2% FBS for flow cytometric analysis of Sca1+/CXCR4+ BMDACs (BDFACSVerse, Becton Dickinson, Franklin Lakes, NJ).
Ex vivo culture of bone marrow-derived angiogenic cells (BMDACs)
BMDACs were cultured as previously described [28] . Briefly, isolated bone marrow MNCs were plated on fibronectin-coated 24-well plates at 2 × 10 6 cell density per well in EGM-2 + 10% FBS medium. Cells were fed with fresh medium on alternate days. On day 5, cells were washed with PBS and labelled with 3 μg/ml acetylated low density lipoprotein (Dil-AcLDL) (Life Technologies) at 37°C in the dark. After 90 min of incubation, cells were labelled with 2 μg/ml FITC-conjugated BS-1 lectin from Ulex europaeus (Sigma) for 30 min at room temperature. Cells were washed with PBS and replaced with fresh medium and imaged with an Olympus IX71 microscope (Olympus Corporation, Tokyo, Japan). The numbers of dil +/ulex + cells were quantified in at least 10 images per well.
In vitro migration assay
BMDACs (5000 cells/transwell) were plated onto the upper chamber of 5 μm pore size 24-well transwells (Corning Inc., Corning, NY) in EBM-2 + 2% FBS. EBM-2 + 2% FBS supplemented with 100 ng/ml mouse recombinant SDF-1 (R&D Systems, Minneapolis, MN) was added to the bottom chamber. BMDACs were allowed to migrate at 37°C for 5 h. Transwells were removed and washed twice with PBS and fixed in ice-cold 70% ethanol for 30 min. Membranes were excised from the transwells and placed on a glass slide. Slides were coverslipped with Vectashield containing DAPI. To examine cellular signaling pathways involved in BMDAC migration, cultured BMDACs were stimulated by mouse recombinant SDF-1 (100 ng/ml) for 15 min prior to protein extraction.
BMDAC conditioned medium
BMDACs were cultured on a 6-well fibronectin-coated plate for 5 days in EGM-2 + 10% FBS. Medium was then replaced with EBM-2 + 2% FBS for 24 h prior to collection. Conditioned media were used to stimulate human umbilical vein endothelial cells (HUVECs) for 24 h prior to tubulogenesis assays. The VEGF levels in conditioned media were quantified by VEGF ELISA.
HUVEC tubulogenesis assay
HUVECs at 70% confluency were washed with PBS and BMDAC conditioned medium was added for 24 h prior to tubulogenesis assay as previously described [29] . HUVECs were plated onto phenol red free, growth factor reduced Matrigel (BD Bioscience) in a 96-well plate (4000 cells/well) in quadruplicate wells and incubated at 37°C for 6 h. Cells were imaged at 20 × magnification. Cell-to-cell branch points were quantified using Image J software.
Real-time quantitative PCR
Muscle tissue was homogenized with TriReagent (Sigma). Total RNA was extracted according to the manufacturer's protocol and 1 μg of RNA was reverse transcribed using an iScript™ cDNA synthesis kit (Bio-Rad Laboratories, Hercules, CA). Primer sequences used are as follows; mouse HIF-1α, forward: 5′-TCCCTTGCTCTTTGTGGTTGGGT, reverse: 5′-AACGTAAGCGCTGACCCAGG. Mouse Bcl-2, forward: CTCGTCGCTACCGT CGTGACTTCG, reverse: CAGATGCCGGTTCAGGTACTCAGTC. Mouse Bax, forward: AAGCTGAGCGAGTGTCTCCGGCG, reverse: GCCACAAAGATG GTCACTGTCTGCC. Mouse 36B4 was used as internal control, forward: 5′-CAACGGCAGCATTTATAACCC, reverse: 5′-CCCATTGATGATGGAGTG TGG (GeneWorks, SA, Australia). A CFX96 Touch™ Real-time PCR detection system was used to perform qPCR (Bio-Rad). PCR conditions were as follows: 3 min at 95°C; 30 s at 95°C, 30 s at 60°C and 30 s at 72°C (× 40 cycles). Melt curve analysis was obtained from 55°C to 95°C with a 0.5°C increment for 10 min. Each run included negative reaction controls. 36B4 was chosen as a housekeeping gene for normalization. Expression levels were calculated by the relative quantification method (ΔΔCt). RT-qPCR was performed in triplicate for each sample.
Protein isolation and Western blotting
Muscle tissue was homogenized with Mammalian Cell Lysis Buffer (50 mM Tris-HCL, 1 mM EDTA, 150 mM sodium chloride, 0.1% sodium dodecyl sulphate (SDS), 0.5% deoxycholic acid sodium salt solution, 1% IGEPAL, 1% protease inhibitor cocktail, 1% phosphatase inhibitor cocktail) (Sigma). Protein concentration was determined by a standard bicinchoninic acid assay (BCA) (Thermo Fisher Scientific, Rockford, IL). Tissue protein (40 μg) or BMDAC protein (15 μg) was loaded onto NuPAGE® Novex 4-12% Bis-Tris Gels (Life Technologies) and separated using SDS-PAGE electrophoresis. Protein was transferred to polyvinylidene fluoride (PVDF) membranes using a semi-dry iBlot gel transfer system (Life Technologies). Membrane was blocked with 1% skim milk in Tris-buffered saline (TBS) for 1 h at room temperature. Primary antibody was incubated at 4°C overnight in 1% BSA at appropriate dilutions for anti-HIF-1α, anti-pCXCR4 (S339), anti-CXCR4, anti-β-actin, anti-tubulin (Abcam, Cambridge, UK), anti-pAkt, anti-Akt, antipJak2, and anti-Jak2 (Cell Signaling Technologies, Danvers, MA). Membrane was washed with 1× TBS-0.05% tween followed by incubation with secondary antibodies conjugated with horseradish peroxidase (HRP) for 2 h at room temperature in 1% skim milk in TBS. Proteins were detected using Amersham enhanced chemiluminescence (ECL) reagent (GE Healthcare Biosciences, Pittsburgh, PA). Western blot densitometry was analyzed using Image Lab™ Software 4.0.1 (Bio-Rad).
ELISA
SDF-1 levels in mouse muscle tissues were quantified using a mouse CXCL12/SDF-1 alpha Quantikine ELISA kit (R&D System) according to manufacturer instructions. The concentrations of VEGF in BMDAC condition media were quantified using a mouse VEGF Quantikine ELISA kit (R&D System) according to manufacturer instructions.
Statistical analysis
All data are expressed as mean ± SEM. Statistical analysis between two groups was performed using unpaired Student's t-test. Statistical analysis between more than two groups was performed using oneway or two-way ANOVA with the Bonferroni post-test as indicated. p b 0.05 was considered statistically significant. All animal experiments consisted of at least n = 5 mice.
Results
Aging markedly impairs neovascularization following ischemia
To assess the effect of aging on ischemia-induced neovascularization, young (2-month) and old (24-month) C57Bl/6J mice were subjected to hindlimb ischemia (HLI). Blood flow recovery was monitored by Laser Doppler perfusion imaging (LDPI). Young mice began to recover blood flow after 3 days post-HLI and reached full recovery at 14 days. By contrast, blood flow recovery was strikingly attenuated in old mice compared to young mice post-HLI (day 14; old: 0.094 ± 0.037 vs. young: 0.939 ± 0.034; p b 0.001) (Fig. 1A) . Histological analysis revealed that the capillary density of the ischemic hindlimb was significantly reduced in old mice compared to young mice at day 14 post-HLI (old: 1.692 ± 0.091 vs. young: 2.010 ± 0.076; p b 0.05) (Fig. 1B) . Arteriolar density (old: 0.057 ± 0.005 vs. young: 0.079 ± 0.010; p b 0.05) and the vessel size (old: 15.76 ± 1.499 vs. young: 28.12 ± 2.481; p b 0.001) were significantly reduced in the old mice ( Fig. 1C and D) . These results indicate that advanced aging impairs ischemia-induced neovascularization, which is accompanied by reduced angiogenesis and arteriogenesis.
Aging impairs ischemia-induced Sca1 +/CXCR4 + progenitor cell mobilization
We investigated the effect of aging on BMDAC mobilization in response to ischemia. By flow cytometry analysis, we compared the levels of BMDACs that co-expressed established murine stem cell marker Sca-1 and the SDF-1 receptor CXCR4 [26, 27] in the mononuclear cell populations of young and old mice. The levels of Sca1 +/CXCR4 + BMDACs were significantly increased in bone marrow of young mice at day 3 post-HLI compared to pre-HLI (young; day 3: 1.970 ± 0.366 vs. pre-HLI: 0.6271 ± 0.078; p b 0.001) ( Fig. 2A) . A significant increase in the Sca1 +/CXCR4 + BMDAC levels was observed in the spleen of young mice at day 3-HLI (young; day 3: 17.010 ± 3.533 vs. pre-HLI: 5.422 ± 1.266, p b 0.001) (Fig. 2B) . Subsequently, the levels of Sca1 +/CXCR4 + BMDACs were significantly increased in the circulating blood at day 7 post-HLI compared to pre-HLI (young; day 7: 27.210 ± 3.162 vs. pre-HLI: 16.770 ± 1.530, p b 0.01) (Fig. 2C) . These data indicate that ischemia induces an increase in Sca1 +/ CXCR4 + BMDAC levels in the bone marrow and the spleen, followed by enhanced mobilization of Sca1 +/CXCR4 + BMDACs into the circulating blood of young mice.
Interestingly, the basal levels of bone marrow Sca1 +/CXCR4 + BMDACs were significantly higher in old mice compared to young mice prior to induction of ischemia (pre-HLI; old: 3.212 ± 0.646 vs. young: 0.6271 ± 0.078; p b 0.001). However, ischemia-induced proliferation of Sca1 +/CXCR4 + BMDACs in the bone marrow was absent in old mice, with no significant increase in the levels of Sca1 +/ CXCR4+ BMDACs at day 3 post-HLI compared to pre-HLI (old; day 3: 3.972 ± 0.616 vs. pre-HLI: 3.212 ± 0.646; p = 0.439), indicating that aging attenuated the proliferation of Sca1+/CXCR4+ BMDACs in the bone marrow in response to ischemia ( Fig. 2A) . Moreover, unlike young mice, there was no significant increase in Sca1 +/CXCR4 + BMDAC levels in the spleen of old mice at any day post-HLI. A slight, but insignificant, increase in the levels of Sca1 +/CXCR4 + BMDACs was observed in the circulating blood of the old mice at day 3 post-HLI compared to pre-HLI (p = 0.173). By day 7, the circulating levels of Sca1 +/CXCR4 + BMDACs were not increased by ischemia in the old mice, which displayed significantly lower Sca1+/CXCR4 BMDAC levels in the blood compared to young mice on day 7 post-ischemia (day 7; old: 17.130 ± 1.089 vs. young: 27.210 ± 3.162; p b 0.05) (Fig. 2C) . Taken together, the results indicate that despite having adequate basal levels of bone marrow Sca1 +/CXCR4 + BMDACs, aging attenuates ischemia-induced proliferation of Sca1 +/CXCR4 + BMDACs in the bone marrow and accumulation in spleen as well as the mobilization of Sca1+/CXCR4+ BMDACs into the circulating blood.
Hypoxia-induced expression of HIF-1α in ischemic tissue is maintained with aging
HIF-1α is a transcription factor which plays a critical role in mediating the adaptive tissue responses to ischemia by regulating the expression of hundreds of genes including those of key angiogenic cytokines such as VEGF and SDF-1 [16, 18] . The mRNA and protein expression levels of HIF-1α in the hindlimb adductor muscle from young and old mice were examined at day 3 post-HLI. Induction of ischemia was associated with a significant increase in HIF-1α mRNA levels in young mice (1.958 ± 0.118-fold increase vs. non-ischemic; p b 0.001) (Fig. 3A) , which was associated with increased HIF-1α protein levels at day 3 post-HLI (2.526 ± 0.458-fold increase vs. non-ischemic; p b 0.01) (Fig. 3B) . By contrast, ischemia-induced upregulation of HIF-1α mRNA was not observed in the tissue of old mice (Fig. 3A) . Nevertheless, HIF-1α protein increased significantly in the ischemic tissue compared to the non-ischemic tissue of old mice at day 3 (2.457 ± 0.169-fold increase vs. non ischemic; p b 0.05). The increased level of HIF-1α protein in old mice was comparable to that of the ischemic tissue of young mice (Fig. 3B) . Consistent with regulation of SDF-1 expression by HIF-1α [17] , the SDF-1 levels were significantly higher in ischemic tissues compared to non-ischemic tissue in both young (ischemic: 4.668 ± 1.564 vs. nonischemic: 1.00 ± 0.052, p b 0.05) and old (ischemic: 6.370 ± 0.993 vs. non-ischemic 2.180 ± 0.397, relative to young non-ischemic, p b 0.005) mice at day 3 at comparable levels (Fig. 3C) .
Given that an early ischemic induction of HIF-1α protein was observed in old mice, we next examined HIF-1α expression levels at a later stage of ischemia. Seven days after induction of ischemia, HIF-1α mRNA and protein levels were higher in the ischemic tissues compared to the non-ischemic tissues in young mice, but this was no longer statistically significant. While ischemia-induced HIF-1α mRNA upregulation remained absent in old mice (Fig. 3D) , HIF-1α protein expression was significantly higher in the ischemic tissues compared to the nonischemic limb in old mice (ischemic: 4.047 ± 0.398 vs. non-ischemic: 2.372 ± 0.310 relative to young non-ischemic; p b 0.01) (Fig. 3E) . By day 7, ischemia-induced SDF-1 levels had declined in both young and old mice without any significant difference (Fig. 3F) .
Intrinsic impairment of ischemia-induced proliferation and mobilization of Sca1+/CXCR4+ BMDACs with aging
Given that ischemia induces comparable augmentation of SDF-1 expression in young and old mice, but reduced circulating Sca1 +/ CXCR4+ BMDACs in old mice, we next investigated whether the mobilization of Sca1+/CXCR4+ BMDACs is intrinsically impaired with age, independent of tissue cytokines. Bone marrow from either young or old mice was transplanted into young recipients. After 6 weeks of bone marrow engraftment, young recipient mice were subjected to hindlimb ischemia (HLI). The levels of Sca1 +/CXCR4 + BMDACs in the bone marrow, spleen and blood were examined.
Bone marrow Sca1+/CXCR4+ BMDAC levels were significantly increased in young recipients with young bone marrow (BM) at day 3 and day 7 post-HLI compared to pre-HLI (young BM; day 3: 2.200 ± 0.094 and day 7: 2.448 ± 0.134 vs. pre-HLI: 1.130 ± 0.202; p b 0.001) (Fig. 4A) . In contrast, ischemia-induced proliferation of bone marrow Sca1 +/CXCR4 + BMDACs was completely abolished in young mice receiving old bone marrow, and no significant increase in Sca1 +/ CXCR4 + BMDACs was observed at any day post-HLI. The levels of Sca1 +/CXCR4 + BMDACs were significantly lower in recipients of old bone marrow compared to those with young bone marrow at day 3 and day 7 post-HLI (day 3; old BM: 1.312 ± 0.069 vs. young BM: 2.200 ± 0.094, p b 0.001; day 7; old BM: 1.460 ± 0.171 vs. young BM: 2.448 ± 0.134, p b 0.001) (Fig. 4A) . Interestingly, comparable levels of Sca1 +/CXCR4 + BMDACs were found in the spleen of recipients that received young or old bone marrow (Fig. 4B) . The circulating Sca1 +/CXCR4 + BMDAC levels were comparably elevated in the blood of young recipient mice transplanted with either young or old bone marrow at day 3 post-HLI compared to pre-HLI (young BM; day 3: 20.460 ± 3.271 vs. pre-HLI: 5.158 ± 1.535; p b 0.001, old BM; day 3: 23.160 ± 2.806 vs. pre-HLI: 4.044 ± 0.981; p b 0.001) (Fig. 4C) . Circulating Sca1+/CXCR4+ BMDAC levels remained significantly increased at day 7 in recipients with young bone marrow compared to pre-HLI (young BM; day 7: 30.790 ± 1.986 vs. pre-HLI: 5.158 ± 1.535; p b 0.001). However, the ischemia-induced BMDAC mobilization to blood was less robust and less sustained in recipients of old marrow by day 7 post-HLI. The circulating levels of Sca1+/CXCR4+ progenitor cells were significantly reduced to less than a third in recipients of old bone marrow compared to those with young bone marrow (day 7; old BM: 8.922 ± 0.849 vs. young BM: 30.790 ± 1.986; p b 0.001) (Fig. 4C) . To determine whether ischemia-induced tissue response in recipient mice with old bone marrow differs from those transplanted with young bone marrow, SDF-1 levels in muscle tissues were examined. The levels of SDF-1 in muscle tissues were similar between recipient mice transplanted either young or old bone marrow at day 3 post-HLI. A decline in SDF-1 levels was observed in all recipients by day 7 post-HLI ( Supplementary Fig. 1 in the online version at http://dx.doi.org/10.1016/j.ijcme.2016.05.005.). These results demonstrate that ischemia-induced proliferation of Sca1+/CXCR4+ progenitor cells in the bone marrow is intrinsically impaired with age and that the mobilization of progenitor cells from aged donors is less sustainable for a prolonged period post-ischemia, despite an equivalent ischemic environment in the young recipients. 
Despite attenuation of proliferative and migratory capacity, the angiogenic capacity of BMDACs is retained with aging
To evaluate in more detail the effects of aging on BMDAC function, we studied ex vivo cultured BMDACs from bone marrow MNCs capable of Dil-AcLDL and lectin uptake [28] . BMDACs from young and old mice at day 3 post-HLI were ex vivo cultured at equivalent densities. The levels of dil+/ulex+ BMDACs from old mice were significantly lower than that from young mice (old: 779.0 ± 156.6 vs. young: 2707.0 ± 247.3; p b 0.001) (Fig. 5A) . Furthermore, BMDACs from old mice exhibited a 58% reduction of SDF-1-stimulated migratory function compared to those from young mice (old: 51.67 ± 6.642 vs. young: 123.80 ± 19.46; **p b 0.01) (Fig. 5B) . Western blot analysis showed that the levels of CXCR4 phosphorylation were similar in BMDACs from young and old mice after SDF-1 stimulation (Fig. 5C ). However, BMDACs from old mice displayed a modest reduction of JAK-2 phosphorylation and a marked increase in total JAK-2 protein levels (Fig. 5D) . AKT phosphorylation was also significantly reduced in BMDACs from old mice (Fig. 5E) . The results indicate that age-related impairment in BMDAC migration could be, partly, associated with decreased JAK-2 and AKT phosphorylation, downstream of CXCR4 signaling pathway.
We next investigated whether old BMDACs retain the capacity to augment angiogenesis in vitro. Vascular endothelial growth factor (VEGF) secretion by BMDACs and the capacity for BMDAC conditioned media to stimulate human umbilical vein endothelial cell (HUVEC) tubule formation were examined. VEGF secretion by old and young BMDACs was not significantly different (old: 2.304 ± 0.326 vs. young: 2.991 ± 1.170 pg/μg; p = 0.647) (Fig. 5F ). HUVECs were cultured in either old or young BMDAC conditioned media for 24 h prior to tubulogenesis assay. The numbers of tubule branch points formed by HUVECs cultured in conditioned media from old BMDACs were comparable to those cultured in conditioned media from young BMDACs (old: 47.33 ± 2.804 vs. young: 54.06 ± 3.718) (Fig. 5G) . These results indicate that BMDACs retain paracrine angiogenic function with age through the secretion of VEGF which promotes and induces tubule formation in endothelial cells.
Old MNCs retained capacity to enhance neovascularization in vivo if mobilized
Having demonstrated that aging is associated with impairment in BMDAC migratory function but preservation of angiogenic capacity, we next determined whether facilitated mobilization of old BMDACs could enhance ischemia-induced neovascularization in old mice. Bone marrow MNCs from old mice were intramuscularly injected into the adductor muscle of old recipients following HLI. Mice that received MNCs demonstrated significant improvement in blood flow recovery compared to mice which received PBS (day 10; old MNCs: 0.642 ± 0.119 vs. PBS: 0.385 ± 0.072; p b 0.001) (Fig. 6A) . Histological analysis showed that capillary density was significantly higher in mice which received MNCs compared to PBS (old MNCs: 1.844 ± 0.124 vs. PBS: 1.164 ± 0.071; p b 0.001) (Fig. 6B) . Arteriolar density and vessel size were also increased in mice which received MNCs compared to PBS (arteriolar density; old MNCs: 0.046 ± 0.004 vs. PBS: 0.028 ± 0.002, p b 0.001. Vessel size; old MNCs: 26.86 ± 1.345 vs. PBS: 21.87 ± 1.224, p b 0.05) (Fig. 6C and D) . To examine whether the presence of old MNCs promotes cytokine production in the muscle tissues, SDF-1 levels were examined in the tissues of old mice. By day 14, the levels of SDF-1 were higher in the muscle tissues of old mice received old MNCs compared to PBS injection, albeit not significant ( Supplementary Fig. 2 in the online version at http://dx.doi.org/10.1016/j.ijcme.2016.05.005.). Ischemia induces apoptosis and the expression of apoptosis-related genes is associated with tissue salvage [30] . Immunofluorescence TUNEL staining of the ischemic tissue showed that the ratio of TUNELpositive cells in old mice received old MNCs was significantly lower than PBS control (old MNCs: 0.007 ± 0.002 vs. PBS: 0.051 ± 0.015, p b 0.01). Next, apoptosis-related gene expressions were examined. Bcl-2 inhibits apoptosis by forming a heterodimer with pro-apoptotic Bax protein [31] . The mRNA expression of Bcl-2 was significantly higher in ischemic tissues of old mice received MNCs compared to that in PBS control (old MNCs: 1.881 ± 0.305 vs. PBS: 0.598 ± 0.278, p b 0.05). Meanwhile, the expression of Bax was significantly lower in ischemic tissues of old mice received MNCs compared to that in PBS control (old MNCs: 0.814 ± 0.269 vs. PBS: 1.664 ± 0.274, p b 0.05). The results indicate that old bone marrow MNCs retain adequate pro-angiogenic function and that facilitated cell mobilization by intramuscular injection promotes neovascularization and improves tissue salvage in old mice post-ischemia.
Discussion
There is an age-related impairment in ischemia-mediated neovascularization [2, 6, 7, 12, 32] , the mechanisms of which are incompletely understood. The salient findings of this study are that: i) aging attenuates the proliferation and accumulation of Sca1 +/CXCR4 + bone marrow-derived angiogenic cells (BMDACs) in bone marrow and spleen following ischemia; ii) aging impairs the intrinsic capacity of BMDACs to mobilize to the circulating blood in response to ischemia; iii) the adaptive responses of ischemic tissue are, at least in part, preserved in old mice with comparable induction of HIF-1α and SDF-1 expression relative to young mice; iv) despite age-related impairment in ischemia-induced proliferation and migration, BMDACs retain paracrine angiogenic function; and v) facilitated mobilization of old BMDACs enhances ischemia induced neovascularization in aged animals. These findings identify a critical role for loss proliferative and migratory capacity of BMDACs in the age-related impairment in ischemia-induced neovascularization. Given that the angiogenic potential of mobilized BMDACs is preserved with age, therapeutic strategies that enhance the efficacy of mobilizing BMDACs could improve clinical outcomes in elderly patients with vascular diseases.
Aging is associated with a severe impairment in ischemia-mediated neovascularization. However, whether this age-related impairment is due to a decline in the regenerative capacity of bone marrow-derived progenitor cells and/or a decline in the pro-regenerative environment in the ischemic tissues remains debated. It has been proposed that an age-dependent exhaustion of progenitor cells underpins the impairment in vascular repair in older animals [4] . In the present study, we demonstrate that the basal Sca1 +/CXCR4 + progenitor cell levels in the bone marrow are not attenuated with age. In line with other studies [33, 34] , age-dependent depletion of progenitor cells is likely to be specific to a subpopulation of intermediate vascular progenitor cells (CD31 +/CD45 −) whereas the primitive progenitor subpopulations (Sca1+/c-kit+/lin−) are not affected by age. In fact, higher basal levels of bone marrow Sca1 +/CXCR4 + BMDACs were found in aged mice prior to ischemia. It has been reported that hematopoietic stem cell expansion is associated with aging. The levels of CD34−/c-kit+/Sca1+ stem cell increase 17-fold from 2 to 18 months of age in C57Bl/6J mice with constant levels of bone marrow cells [35] . However, it is accompanied by reduction in self-renewal and lymphoid differentiation potentials [35] [36] [37] [38] [39] . Consistently, despite having adequate bone marrow Sca1 +/CXCR4 + BMDACs at basal levels, ischemia-induced BMDAC proliferation is attenuated in old mice. In young mice, ischemia induces accumulation of Sca1 +/CXCR4 + BMDACs in the spleen followed by BMDAC mobilization into the circulation. The spleen is a transient reservoir for progenitor cell trafficking [40] . It has been demonstrated that approximately 70% of endothelial progenitor cells home to the spleen following intravenous injection [41] . The spleen may also serve as an additional source of progenitor cell production. In mice, mononuclear cells isolated from spleen homogenates can differentiate into endothelial progenitor cells in endothelial-specific medium [42, 43] , contributing, at least partly, to a portion of the circulating progenitor cell population. In marked contrast to young mice, the accumulation of Sca1 +/CXCR4 + BMDACs is abolished in the spleen of old mice post-ischemia. Furthermore, aging is associated with a loss of progenitor cell mobilization into the circulation in response to ischemia, with circulating Sca1 +/CXCR4 + BMDAC levels post-ischemia being not significantly different to the basal pre-ischemic levels in the blood of old mice. The dynamics of ischemia-induced progenitor cell mobilization is markedly impaired with aging.
It has been suggested that the decrease in progenitor cell mobilization with aging is due to an age-related impairment of HIF-1α, highlighting an aging effect on the pro-regenerative environment in ischemic tissues [12, 33] . The current study, however, shows that ischemia induces similar levels of HIF-1α and SDF-1 in old mice compared to those found in young mice at day 3 post-ischemia. In comparison to the hindlimb ischemia model used in this study, Chang et al. demonstrated an attenuation of HIF-1α expression in aged mice using a murine skin flap model [33] . This discrepancy may reflect inherent differences between skin and muscle tissues and suggests that tissue differences may exist in terms of the effect of aging on repair mechanisms. Although the expression levels of HIF-1α in skin and skeletal muscle tissues have not been directly compared under ischemic conditions, Chen et al. has demonstrated that murine dorsal skin wounds are significantly more hypoxic and exhibit higher levels of HIF-1α compared to oral mucosal wounds under basal and stressed conditions [44] . It is likely that regulation of HIF-1α is tissue-specific and is differentially expressed depending on oxygen sensitivity and metabolic requirements. Therefore, the disparity of aging effects on the ischemiamediated HIF-1α upregulation could be, partly, explained by the use of different murine models with our current findings being more directly relevant to the effects of aging on the regenerative response to vascular occlusion.
Interestingly, we found that old mice display a prolonged elevation of HIF-1α expression in both non-ischemic and ischemic tissues while the ischemia-induced HIF-1α expression returns to basal level in young mice after 7 days of ischemia. This may indicate an age-related loss of HIF-1α regulation where the elevated HIF-1α fails to return to the basal level after ischemia. The prolonged elevation of HIF-1α could be disadvantageous and detrimental. For example, a transgenic mouse model with a constitutive HIF-1α expression develops cardiomyopathy with age as a result of high energy demand in the heart. In parallel, patients with end-stage heart failure are found to have an increased stabilization of HIF-1α in the heart [45] . Together with the current findings, this suggests that aging may be associated with a loss of HIF-1α regulation in response to stress stimuli.
Having identified an age-related impairment in vasculogenesis characterized by failure in ischemia-induced progenitor cell proliferation and mobilization, we used bone marrow transplantation experiments to further characterize the role of aged-related changes in the intrinsic function of BMDACs. These experiments showed that ischemia-induced proliferation of Sca1 +/CXCR4 + BMDACs is abolished in young recipients of old bone marrow. Furthermore, recipients of old marrow exhibit a less robust and less sustained mobilization of Sca1 +/CXCR4 + BMDACs following induction of ischemia. These findings demonstrate that transplantation of old bone marrow into a youthful host tissue environment could not restore the vasculogenic response to ischemia, consistent with an intrinsic age-related BMDAC dysfunction. Interestingly, the levels of Sca1+/CXCR4+ BMDAC in the spleen are independent of donor age. By transplanting GFP + donor cells into GFP − recipient mice, Filip et al. reported that N 40% of the recipient's own cells remained in the spleen after the bone marrow transplantation, while b 20% of the recipient's cells are found in the bone marrow and circulating blood [46] . The chimerism in the spleen may explain the similar levels of Sca1 +/CXCR4 + progenitor cells found in recipients with either young or old bone marrow.
We used in vitro assays of cultured BMDACs to further characterize the effects of aging on progenitor cell function. Consistent with our in vivo findings, ex vivo cultured BMDACs from old mice are impaired with respect to migratory and proliferative function. In contrast, we found that old BMDACs retain VEGF secretory function and the capacity to induce angiogenesis by paracrine mechanisms. Similarly, Williamson et al. reported that outgrowth endothelial progenitor cells (OECs) derived from the peripheral blood of elderly aged 50-70 years display a functional impairment in SDF1-stimulated migration with preserved tube-forming ability [47] . Together, this suggests that the angiogenic functions of BMDACs are differentially affected by age.
Cell migration is mediated by SDF-1 binding to its receptor CXCR4, which is associated with the activation of JAK and AKT signaling [22] [23] [24] . In this study, we show that the phosphorylation levels of JAK-2 and AKT are markedly reduced in BMDACs from old mice, indicating a possible link between impaired cell migration and age-related alteration in cell signaling pathways. Consistent with this, JAK-2 phosphorylation is decreased in the hippocampus of short-lived klotho mutant mice [48] . A reduction in JAK-2 phosphorylation has also been reported in progenitor cells isolated from the peripheral blood of elderly, which is associated with decreased cell migration and adhesion in vitro [49] . On the other hand, age-related reduction in AKT phosphorylation has been demonstrated in different cell types and tissues, suggesting that it may be a general impairment in response to various stimuli with age.
We further demonstrated that the angiogenic capacity in old BMDACs remains functional in vivo. Bone marrow MNCs from old mice retain sufficient angiogenic potential to promote angiogenesis and arteriogenesis when cells are intramuscularly injected to the ischemic tissues of old mice. In addition, the presence of old MNCs improves tissue salvage by reducing apoptotic levels in the ischemic tissues of old mice. Direct cell administration by intramuscular injection to the ischemic tissues bypasses the need of progenitor cells to exit from the bone marrow and mobilize into the circulation, as well as minimizes cell retention in organs, such as the spleen and liver. This finding recapitulates the success of clinical studies involving autologous bone marrow MNC implantation [50] [51] [52] [53] . Interestingly, saline injection slightly increased the blood flow in old mice post-ischemia, which may be explained by the vasodilatory effect generated by the injection [54] . However, there are some limitations. Although it is expected that Sca1 +/CXCR4+ BMDACs are present in the bone marrow MNCs, we could not exclude the possibility that other subpopulations of angiogenic progenitor cells facilitate the blood flow recovery in the old mice following ischemia. The limited amount of Sca1 +/CXCR4 + BMDACs present in the bone marrow poses a difficulty in harvesting sufficient quantity for injection. Cell isolation by FACS or magnetic bead sorting may affect cell viability and damage the intrinsic angiogenic potential of Sca1+/CXCR4+ BMDACs from old mice.
In conclusion, age-related impairment in neovascularization is attributable to a decline in ischemia-induced bone marrow-derived angiogenic cell proliferation and mobilization to the circulating blood with a partial preservation of HIF-1α-mediated tissue angiogenic response with age. Furthermore, our findings suggest that the intrinsic functions of BMDACs are differentially affected by age with preservation of paracrine-mediated angiogenic function, but impairment in migratory capacity. This study provides further understanding to the mechanisms involved in age-related impairment in ischemia-induced neovascularization. Strategies that enhance the vasculogenic response in elderly patients by promoting progenitor cell proliferation and mobilization may have potential to enhance clinical outcomes in patients suffering ischemic manifestations of athero-occlusive disease.
Supplementary data to this article can be found online at http://dx. doi.org/10.1016/j.ijcme.2016.05.005.
